Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06549218Not ApplicableRecruiting

Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project

Role: collaborator

NCT07160348Not Yet Recruiting

Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek

Role: collaborator

NCT05447013Phase 1Unknown

Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients

Role: collaborator

NCT05246423Unknown

Ergospirometry in Paroxysmal Atrial Fibrillation Prognosis

Role: collaborator

NCT02383329Not ApplicableCompleted

Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight

Role: collaborator

NCT02283203Phase 4Completed

A New Formulation of Intravenous Paracetamol for Fever Management

Role: collaborator

All 6 trials loaded